Significant service restrictions in the lending area from 17 March!

Result: Ruxolitinib for the treatment of patients with steroid-refractory GVHD

Title:
Published:
Freiburg : Universität, 2019
Scope:
1 Online-Ressource
Format:
eBook
Language:
English
Notes:
Immunotherapy. - 10, 5 (2018) , 391-402, ISSN: 1750-7448
DOI:
10.2217/imt-2017-0156